Nodular regenerative hyperplasia: The main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities
Georgia Malamut(Délégation Paris 5), Christophe Cellier(Assistance Publique – Hôpitaux de Paris), Marianne Ziol(Assistance Publique – Hôpitaux de Paris), Dominique Béchade(Délégation Paris 5), Felipe Suárez(Hôpital Necker-Enfants Malades), Jean‐François Viallard(Université de Bordeaux), Anne Sophie Lascaux(Hôpitaux Universitaires Henri-Mondor), Olivier Hermine(Centre National de la Recherche Scientifique), Virginie Verkarre(Université Paris Cité), Michel Beaugrand(Hôpital Jean-Verdier), Thierry Poynard(Centre National de la Recherche Scientifique)
Cited by 188
Related Papers
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten‐related disorders
|United European Gastroenterology Journal|2019|987
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821